---
blocking_issues_count: 1
warnings_count: 4
tasklist_ready: false
---

## Findings

### BLOCKING

- **[BLOCKING] Parseability**: `extraction.md` has blank lines before YAML frontmatter delimiter.
  - **Location**: `extraction.md:1-2`
  - **Evidence**: The file begins with two blank lines before the opening `---`. YAML frontmatter parsers (including those used by `sc:tasklist`'s splitter) require `---` on line 1. Content before the delimiter causes the frontmatter block to be treated as body text, making all 12 frontmatter fields (including `functional_requirements`, `complexity_score`, `total_requirements`) unparseable.
  - **Fix guidance**: Remove all blank lines before the opening `---` so it appears on line 1 of the file.

### WARNING

- **[WARNING] Traceability**: FR-010 (report body structure with B-NNN/W-NNN/I-NNN identifiers and specific sections) lacks an explicit deliverable in the roadmap.
  - **Location**: `extraction.md:FR-010` → `roadmap.md:Phase 2 deliverables`
  - **Evidence**: FR-010 requires "Summary, Blocking Issues (B-NNN IDs with Dimension/Location/Detail/Fix), Warnings (W-NNN), Info (I-NNN), and Validation Metadata sections." Phase 2 deliverable 1 describes `build_reflect_prompt` and `build_merge_prompt` but never mentions the B-NNN/W-NNN/I-NNN identifier scheme or the specific section structure. The requirement is implicitly covered (the prompt would instruct this format) but not explicitly traceable to a numbered deliverable.
  - **Fix guidance**: Add an explicit sub-bullet under Phase 2 deliverable 1 stating: "Embed required report body structure: Summary, Blocking Issues (B-NNN), Warnings (W-NNN), Info (I-NNN), Validation Metadata sections per FR-010."

- **[WARNING] Cross-file consistency**: SC-008 test count mismatch between extraction and test-strategy.
  - **Location**: `extraction.md:SC-008` vs `test-strategy.md:Section 2`
  - **Evidence**: Extraction SC-008 states "All 7 unit tests and 4 integration tests from section 10 pass." Test-strategy defines 20 tests total: 7 unit + 6 integration + 4 E2E + 3 architecture. The integration test count (4 vs 6) and total test count (11 vs 20) are inconsistent. The extraction appears to quote the original spec while the test-strategy expanded coverage.
  - **Fix guidance**: Update extraction SC-008 to match test-strategy totals: "All 20 tests pass (7 unit + 6 integration + 4 E2E + 3 architecture)" or align the test-strategy to the spec's original scope and explicitly document the expansion.

- **[WARNING] Cross-file consistency**: NFR-007 (subprocess isolation for confirmation bias prevention) has no corresponding test in the test-strategy.
  - **Location**: `extraction.md:NFR-007` → `test-strategy.md:Section 2` (absent)
  - **Evidence**: NFR-007 requires "Validation subprocess runs with context independence from the generation pipeline to eliminate confirmation bias (separate Claude subprocess, not in-session)." No test in the test-strategy verifies this property. AT-01 checks reverse imports but not subprocess isolation. VM-8 references NFR-001, NFR-002, NFR-004 but not NFR-007.
  - **Fix guidance**: Add an architecture test (e.g., AT-04) that verifies `execute_validate` spawns a `ClaudeProcess` rather than running validation in-session. Alternatively, add NFR-007 coverage to AT-03 or document why it is covered by design (subprocess usage is inherent in `ClaudeProcess`).

- **[WARNING] Decomposition**: Phase 4 deliverable 2 is a compound deliverable combining 4 distinct behaviors.
  - **Location**: `roadmap.md:Phase 4, deliverable 2`
  - **Evidence**: This single deliverable combines: (a) call `execute_validate()` after pipeline success, (b) inherit options from parent invocation, (c) skip when `--no-validate` is set, (d) skip when `--resume` halts on a failed step. These are 4 independent behavioral changes to `executor.py` joined by implicit "and". `sc:tasklist` would need to split this into separate tasks.
  - **Fix guidance**: Split into separate deliverables: "2a. Auto-invoke `execute_validate()` after 8-step pipeline success, inheriting parent options", "2b. Skip validation when `--no-validate` is set", "2c. Skip validation when `--resume` pipeline halts on a failed step."

### INFO

- **[INFO] Structure**: Roadmap uses sequential numbering (1, 2, 3...) within phases rather than globally unique deliverable IDs (e.g., D-001).
  - **Location**: `roadmap.md:Phases 1-5`
  - **Evidence**: Deliverables are numbered locally per phase (Phase 1: 1, 2, 3; Phase 2: 1, 2, 3, 4; etc.). No global D-NNN scheme is used. This prevents duplicate-ID detection (Dimension 2) from being meaningful and makes cross-document reference less precise.
  - **Fix guidance**: Consider adding globally unique deliverable IDs (D-001 through D-N) for unambiguous cross-referencing, especially since the test-strategy references deliverables by phase position which is fragile.

- **[INFO] Cross-file consistency**: `info_count` field from FR-009 is not validated by any gate criterion.
  - **Location**: `extraction.md:FR-009` vs `roadmap.md:Phase 1, deliverable 2`
  - **Evidence**: FR-009 requires 6 frontmatter fields including `info_count`. REFLECT_GATE checks 3 fields (`blocking_issues_count`, `warnings_count`, `tasklist_ready`). ADVERSARIAL_MERGE_GATE checks 5 fields (adding `validation_mode`, `validation_agents`). Neither gate validates `info_count`. The field could be missing from reports without triggering a gate failure.
  - **Fix guidance**: Add `info_count` to REFLECT_GATE's required frontmatter fields, or document why it is intentionally excluded from gate enforcement.

## Summary

| Severity | Count |
|----------|-------|
| BLOCKING | 1 |
| WARNING | 4 |
| INFO | 2 |
| **Total** | **7** |

**Overall Assessment**: The roadmap is **not ready for tasklist generation** due to 1 blocking parseability defect in `extraction.md`. The fix is trivial (remove blank lines before frontmatter). The 4 warnings identify real gaps in traceability, cross-file consistency, and decomposition that should be addressed to improve tasklist generation quality but do not block it. The roadmap itself is well-structured with clear phasing, proper dependency ordering, and comprehensive coverage of the specification requirements.

## Interleave Ratio

**Formula**: `interleave_ratio = unique_phases_with_deliverables / total_phases`

**Values**:
- Total phases: 5 (Phase 1, Phase 2, Phase 3, Phase 4, Phase 5)
- Phases with deliverables: 5 (all phases contain explicit deliverables)
- `unique_phases_with_deliverables = 5`

**Result**: `interleave_ratio = 5 / 5 = 1.0`

**Assessment**: Ratio 1.0 is within the valid range [0.1, 1.0]. Test activities are not back-loaded — the test-strategy documents a 1:1 interleaving ratio with tests written alongside implementation in each phase (confirmed by test-strategy Section 3 "Interleaving Schedule"). Phase 5 contains verification and E2E tests but unit and integration tests are distributed across Phases 1-4.
